LOS ANGELES, Jan. 7, 2026 /PRNewswire/ — Westcove Partners, LLC (“Westcove”), a highly specialized investment bank, announced that it acted as the exclusive financialLOS ANGELES, Jan. 7, 2026 /PRNewswire/ — Westcove Partners, LLC (“Westcove”), a highly specialized investment bank, announced that it acted as the exclusive financial

Westcove Advises Tampa Bay Medical Research in its Partnership with Alcanza Clinical Research

LOS ANGELES, Jan. 7, 2026 /PRNewswire/ — Westcove Partners, LLC (“Westcove”), a highly specialized investment bank, announced that it acted as the exclusive financial advisor to Tampa Bay Medical Research (“TBMR”) in its partnership with Alcanza Clinical Research, a portfolio company of Martis Capital (“Martis”). The terms of the transaction were not disclosed. Westcove’s deal team included Justin Hand, Managing Director; Bill Bolding, Vice President; Geno Catalano, Associate; and Andrew Hartono, Analyst.

Tampa Bay Medical Research is an independent clinical research site with dedicated facilities in Clearwater and Largo, Florida. The Company conducts Phase II–IV trials across a broad range of therapeutic areas, including MASH/MASLD, metabolic disease, endocrinology, vaccines, and others. Backed by experienced leadership, strong sponsor relationships, and a community-first approach, the Company consistently delivers reliable enrollment and high-quality trial execution.

Dr. Sureka Bollepalli, owner of TBMR, stated, “The Westcove team was always available, communicated clearly, and kept the process organized from start to finish. It was clear they had our best interests in mind, which gave us confidence throughout the transaction.”

Bill Bolding, Vice President of Westcove, commented, “Dr. Bollepalli has built a high-quality clinical research platform with a strong track record of execution. Alcanza is a natural partner for TBMR, bringing scale and infrastructure that support continued growth while preserving the strengths of the existing site. We were pleased to advise TBMR on this transaction.”

About Tampa Bay Medical Research
Tampa Bay Medical Research is an independent clinical research organization dedicated to advancing health and quality of life in its community through high-quality clinical trials. TBMR collaborates with sponsors and contract research organizations across multiple therapeutic areas, offering clinical expertise, disciplined operations, and patient-centered care to support the development of new therapies. For more information, visit www.tampabaymedicalresearch.com.

About Alcanza Clinical Research
Alcanza is an integrated network of research facilities dedicated to accelerating the development of new therapies by reducing barriers to clinical research participation. With locations across the United States, including Puerto Rico, Alcanza collaborates with medical providers and community organizations to deliver high-quality clinical research opportunities, emphasizing inclusivity and patient safety. For more information, visit www.alcanzaclinical.com.

About Martis Capital Management
Martis Capital is a healthcare-focused private equity firm that partners with founders, entrepreneurs, and management teams to build leading growth platforms in middle-market healthcare. With offices in Washington, D.C., San Francisco, and Miami, Martis Capital’s mission is to advance healthcare innovation by supporting companies that improve patient outcomes, enhance efficiency, and expand access to care. For more information, visit www.martiscapital.com.

About Westcove Partners
Westcove Partners is a premier healthcare-focused investment bank specializing in mergers and acquisitions, debt and equity financings, and other complex corporate finance transactions. The firm is dedicated to advising founder-operated businesses, tailoring its advisory services to address the unique challenges and opportunities these businesses face. For more information, visit www.westcove.com.

Contact:
Andrew Hartono, ahartono@westcove.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/westcove-advises-tampa-bay-medical-research-in-its-partnership-with-alcanza-clinical-research-302655788.html

SOURCE Westcove Partners, LLC

Market Opportunity
Marina Protocol Logo
Marina Protocol Price(BAY)
$0.03231
$0.03231$0.03231
+1.41%
USD
Marina Protocol (BAY) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Real Estate Tokenization: Why Legal Architecture Matters More Than Technology

Real Estate Tokenization: Why Legal Architecture Matters More Than Technology

Oleg Lebedev on How Corporate Law Determines the Success or Failure of Digital Asset Projects. Real estate tokenization is gaining momentum worldwide.Visit Website
Share
Coinstats2026/01/10 02:00
Fed Makes First Rate Cut of the Year, Lowers Rates by 25 Bps

Fed Makes First Rate Cut of the Year, Lowers Rates by 25 Bps

The post Fed Makes First Rate Cut of the Year, Lowers Rates by 25 Bps appeared on BitcoinEthereumNews.com. The Federal Reserve has made its first Fed rate cut this year following today’s FOMC meeting, lowering interest rates by 25 basis points (bps). This comes in line with expectations, while the crypto market awaits Fed Chair Jerome Powell’s speech for guidance on the committee’s stance moving forward. FOMC Makes First Fed Rate Cut This Year With 25 Bps Cut In a press release, the committee announced that it has decided to lower the target range for the federal funds rate by 25 bps from between 4.25% and 4.5% to 4% and 4.25%. This comes in line with expectations as market participants were pricing in a 25 bps cut, as against a 50 bps cut. This marks the first Fed rate cut this year, with the last cut before this coming last year in December. Notably, the Fed also made the first cut last year in September, although it was a 50 bps cut back then. All Fed officials voted in favor of a 25 bps cut except Stephen Miran, who dissented in favor of a 50 bps cut. This rate cut decision comes amid concerns that the labor market may be softening, with recent U.S. jobs data pointing to a weak labor market. The committee noted in the release that job gains have slowed, and that the unemployment rate has edged up but remains low. They added that inflation has moved up and remains somewhat elevated. Fed Chair Jerome Powell had also already signaled at the Jackson Hole Conference that they were likely to lower interest rates with the downside risk in the labor market rising. The committee reiterated this in the release that downside risks to employment have risen. Before the Fed rate cut decision, experts weighed in on whether the FOMC should make a 25 bps cut or…
Share
BitcoinEthereumNews2025/09/18 04:36
Why Altcoins Could Be Primed for 5–10x Gains After Years of Consolidation

Why Altcoins Could Be Primed for 5–10x Gains After Years of Consolidation

Altcoins are poised for a potential 5-10x surge after long consolidation, with dominance set to rise in 2025 based on historical trends. The cryptocurrency market
Share
LiveBitcoinNews2026/01/10 02:32